Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections

BACKGROUND AND OBJECTIVE: Potential hepatoxicity is an important clinical concern when administering immunosuppressive therapies to patients infected by hepatitis B virus (HBV). Tumor necrosis factor inhibitors (anti-TNF) increase the likelihood of hepatitis consequent to HBV reactivation, but repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Ying-Ming, Lai, Mei-Shu, Chan, K. Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919014/
https://www.ncbi.nlm.nih.gov/pubmed/29694398
http://dx.doi.org/10.1371/journal.pone.0196210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919014/
https://www.ncbi.nlm.nih.gov/pubmed/29694398
http://dx.doi.org/10.1371/journal.pone.0196210

Ejemplares similares